参考文献/References:
1 Korpelainen EL.Endothelial receptor tyrosine kinases active the STAT signaling pathway:mutant Tie-2 causing venous malformations signals a distinct STAT activation response.Oncogene,1999,18(1):1-8.
2 Carlson TR,Feng Y,Maisonpierre PC,et al.Direct cell adhesion to the angiopoietins mediated by integrins.J Biol Chem,2001,276(28):26516-26525.
3 Kim I,Kim HG,So JN,et al.Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3’-kinase/Akt signal transduction pathway.Cire Res,2000,86(1):24-29.
4 Cardone MH,Roy N,Stennicke HR,et al.Regulation of cell death protease caspase-9 by phosphorylation.Science,1998,282(5392):1318-1321.
5 Kim I,Kim HG,Moon SO,et al.Angiopoietin-1 induces endothelial sproutin through the activation of facal adhesion kinase and plasmin secretion.Circ Res,2000,86(9):952-959.
6 Gamble JR,Drew J,Trezise L,et al.Angiopoietin-1 is an antipermeability and anti-inflammatory agent in vitro and targets cell junctions.Circ Res,2000,87(7):603-607.
7 Holash J,Maisonpierre PC,Compton D,et al.Vessel cooption,regression,and growth in tumors mediated by angiopoietins and VEGF.Science,1999,284(5422):1994-1998.
8 Chen SL,Zhang BR,Mei J,et al.Induction of angiogenesis in ischemic myocardium by adenovirus mediated angiopoietin-1 gene transfer,an experimental study.ZhongHua Yi Xue Za Zhi,2003,83(8):637-640.
9 Eggert A,Ikegaki N,Kwiatkowski J,et al.High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas.Clin Cancer Res,2000,6(5):1900-1908.
10 Joussen AM,Poulaki V,Tsujikawa A,et al.Suppression of diabetic retiopaty with angiopoietin-1.Am J Pathol,2002,160(5):1683-1693.
相似文献/References:
[1]黄建敏,解朋,刘晓梅,等.以整合素αvβ3为靶点的肿瘤分子显像及靶向治疗[J].国际放射医学核医学杂志,2015,39(3):256.[doi:10.3760/cma.j.issn.1673-4114.2015.03.015]
Huang Jianmin,Xie Peng,Liu Xiaomei,et al.Integrins αvβ3 in molecular imaging and targeted therapy of neoplasms[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):256.[doi:10.3760/cma.j.issn.1673-4114.2015.03.015]
[2]郝玉美,贺欣,宋娜玲.靶向肿瘤新生血管整合素αvβ3受体显像研究现状及进展[J].国际放射医学核医学杂志,2014,38(3):179.[doi:10.3760/cma.j.issn.1673-4114.2014.03.010]
Hao Yumei,He Xin,Song Naling.Progress on tumor angiogenesis imaging targeting integrin αvβ3 receptor[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(1):179.[doi:10.3760/cma.j.issn.1673-4114.2014.03.010]
[3]张一秋,石洪成.肝细胞癌肿瘤新生血管影像学评价的研究进展[J].国际放射医学核医学杂志,2013,37(1):60.[doi:10.3760/cma.j.issn.1673-4114.2013.01.015]
ZHANG Yi-qiu,SHI Hong-cheng.Advances in assessment of imaging examination for tumor neoangiogenesis induced by hepatocellular carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(1):60.[doi:10.3760/cma.j.issn.1673-4114.2013.01.015]
[4]陈敏,魏玲格,刘晓梅.肿瘤血管生成的分子影像学研究进展[J].国际放射医学核医学杂志,2012,36(2):65.[doi:10.3760/cma.j.issn.1673-4114.2012.02.001]
CHEN Min,WEI Ling-ge,LIU Xiao-mei.Advances of molecular imaging in tumor angiogenesis[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(1):65.[doi:10.3760/cma.j.issn.1673-4114.2012.02.001]
[5]付彤,瞿卫,王峰.CDl3/氨基肽酶N在新生血管成像中的应用价值[J].国际放射医学核医学杂志,2011,35(6):321.[doi:10.3760,cma.j.issn.1673-4114.2011.06.001]
FU Tong,Qu Wei,WANG Feng.The application of CDl3/aminopeptidase N in the angiogenesis imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(1):321.[doi:10.3760,cma.j.issn.1673-4114.2011.06.001]